- Home
- MBRX vs OPI Comparison
MBRX vs OPI Comparison
Compare MBRX & OPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- OPI
- Stock Information
- Founded
- MBRX 2015
- OPI 2009
- Country
- MBRX United States
- OPI United States
- Employees
- MBRX N/A
- OPI N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- OPI Real Estate Investment Trusts
- Sector
- MBRX Health Care
- OPI Real Estate
- Exchange
- MBRX Nasdaq
- OPI Nasdaq
- Market Cap
- MBRX 17.1M
- OPI 16.6M
- IPO Year
- MBRX 2016
- OPI 2009
- Fundamental
- Price
- MBRX $0.38
- OPI $0.23
- Analyst Decision
- MBRX Strong Buy
- OPI
- Analyst Count
- MBRX 4
- OPI 0
- Target Price
- MBRX $5.00
- OPI N/A
- AVG Volume (30 Days)
- MBRX 4.0M
- OPI 627.3K
- Earning Date
- MBRX 11-07-2025
- OPI 10-29-2025
- Dividend Yield
- MBRX N/A
- OPI 13.28%
- EPS Growth
- MBRX N/A
- OPI N/A
- EPS
- MBRX N/A
- OPI N/A
- Revenue
- MBRX N/A
- OPI $466,972,000.00
- Revenue This Year
- MBRX N/A
- OPI N/A
- Revenue Next Year
- MBRX N/A
- OPI N/A
- P/E Ratio
- MBRX N/A
- OPI N/A
- Revenue Growth
- MBRX N/A
- OPI N/A
- 52 Week Low
- MBRX $0.25
- OPI $0.18
- 52 Week High
- MBRX $3.65
- OPI $2.44
- Technical
- Relative Strength Index (RSI)
- MBRX 32.94
- OPI 49.66
- Support Level
- MBRX $0.35
- OPI $0.19
- Resistance Level
- MBRX $0.62
- OPI $0.23
- Average True Range (ATR)
- MBRX 0.05
- OPI 0.02
- MACD
- MBRX -0.02
- OPI 0.00
- Stochastic Oscillator
- MBRX 8.19
- OPI 71.80
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.